A phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line in advanced gastric cancer

被引：0
|
作者：
Hironaka, Shuichi
Kadowaki, Shigenori
Izawa, Naoki
Nishina, Tomohiro
Yamanaka, Takeharu
Minashi, Keiko
Muro, Kei
Sunakawa, Yu
Kajiwara, Takeshi
Hayashi, Yuichiro
Kawakami, Yutaka
Nakajima, Takako Eguchi
机构：
[1] Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan
[2] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[3] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan
[4] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[5] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
[6] Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
[7] USC Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[8] Natl Hosp Org Shikoku Canc Ctr, Dept Gastrointestinal Med Oncol, Matsuyama, Ehime, Japan
[9] Keio Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
352
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Ramucirumab: second-line therapy for gastric cancer
    Sasako, Mitsuru
    LANCET ONCOLOGY, 2014, 15 (11): : 1182 - 1184
  • [22] Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
    Kim, Seung Tae
    Sa, Jason K.
    Oh, Sung Yong
    Kim, Kyung
    Hong, Jung Yong
    Kang, Won Ki
    Kim, Kyoung-Mee
    Lee, Jeeyun
    GENOME MEDICINE, 2021, 13 (01)
  • [23] Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
    Seung Tae Kim
    Jason K. Sa
    Sung Yong Oh
    Kyung Kim
    Jung Yong Hong
    Won Ki Kang
    Kyoung-Mee Kim
    Jeeyun Lee
    Genome Medicine, 13
  • [24] Phase II Study of Weekly Paclitaxel as a Second-line Treatment for S-1-refractory Advanced Gastric Cancer
    Matsuda, Goro
    Kunisaki, Chikara
    Makino, Hirochika
    Fukahori, Michiko
    Kimura, Jun
    Sato, Tsutomu
    Oshima, Takashi
    Nagano, Yasuhiko
    Fuii, Shoichi
    Takagawa, Ryo
    Kosaka, Takashi
    Ono, Hedetaka A.
    Akiyama, Hirotoshi
    Ichikawa, Yasushi
    ANTICANCER RESEARCH, 2009, 29 (07) : 2863 - 2867
  • [25] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    BMC Cancer, 20
  • [26] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [27] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    BMC CANCER, 2020, 20 (01)
  • [28] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    Investigational New Drugs, 2020, 38 : 533 - 540
  • [29] Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With Advanced Gastric Cancer (YCOG1601)
    Sato, Sho
    Kunisaki, Chikara
    Tamura, Yuko
    Yago, Akikazu
    Kasahara, Kohei
    Sato, Tsutomu
    Kondo, Hiroki
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (12) : 5663 - 5669
  • [30] A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer
    Bendell, Johanna C.
    Percent, Ivor John
    Weaver, Robert Waide
    Chua, Cynthia Coo
    Xiong, Henry Q.
    Cohn, Allen Lee
    Zakari, Ahmed
    Singh, Jaswinder
    Kozloff, Mark
    Lietman, Caressa
    Lane, Cassie Michelle
    Jones, Suzanne Fields
    Finney, Lindsey H.
    Carmody, Sean
    Womack, Mark Sanders
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345